Study Summary
This trial will look at the effects of a common treatment for adenomyosis (radiofrequency ablation) by studying tissue that has been removed during a planned hysterectomy.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: Day of intervention within 4 hours of RF (radiofrequency) treatment and 2 hours of completion of hysterectomy
Hour 4
Post-operative evidence of adenomyoma tissue ablation as assessed by pathological analysis
Trial Safety
Safety Progress
Trial Design
0 Treatment Group
20 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: day of intervention within 4 hours of rf (radiofrequency) treatment and 2 hours of completion of hysterectomy
Who is running the clinical trial?
Hologic, Inc.Industry Sponsor
45 Previous Clinical Trials
57,830 Total Patients Enrolled
University of Texas Southwestern Medical CenterLead Sponsor
953 Previous Clinical Trials
608,817 Total Patients Enrolled
2 Trials studying Adenomyosis
100 Patients Enrolled for Adenomyosis
Kimberly Kho, MDPrincipal InvestigatorUT Southwestern Medical Center
1 Previous Clinical Trials
74 Total Patients Enrolled
Eligibility Criteria
Age 18+ · Female Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You are considered to be a suitable candidate for surgery.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments